However, as a consequence of mutations in DPC4 and/ or hyperactivation of non-Smad pathways TGF-β can loose its tumour-suppressive function and in later stages of tumour development can become a potent tumour promoter [5]. The gene discussed is SMAD4; the disease is neoplasm.